| Autor: |
Hulsebos TJ; Department of Human Genetics, Academic Medical Center, University of Amsterdam, The Netherlands., Bijleveld EH, Oskam NT, Westerveld A, Leenstra S, Hogendoorn PC, Bras J |
| Jazyk: |
angličtina |
| Zdroj: |
Genes, chromosomes & cancer [Genes Chromosomes Cancer] 1997 Apr; Vol. 18 (4), pp. 279-85. |
| Abstrakt: |
Recently, we reported a new amplification event that involves marker D17S67 in 17p12 in three malignant astrocytomas of patients with a very short survival. The amplified region may contain an oncogene implicated in astrocytoma tumorigenesis. To determine the extent of the amplified regions, we constructed a yeast artificial chromosome contig spanning the D17S67 region and tested the amplification status of markers that map to the contig. We determined a commonly amplified region between markers D17S1311 and D17S1875 with a maximal length of 1,630 kb. By using marker 745R, from within the commonly amplified region, we screened 60 high-grade astrocytomas but could not detect additional tumors with the amplification event. This suggests that the incidence of the amplification event in high-grade astrocytoma is low (5%). It has recently been shown by comparative genomic hybridization that amplification of 17p11-p12 is a frequent event in high-grade osteosarcomas, occurring in 20-30% of cases. Since the commonly amplified region is within 17p12, we tested 745R in 20 osteosarcomas, including 6 lung metastases, and detected amplification in 9 cases (45%). Marker 745R was found to be amplified in 4 of the 6 lung metastases (66%). From this frequent involvement and the association with clinically aggressive astrocytomas we conclude that for both tumor types presence of the amplification event seems to correlate with aggressive clinical behaviour. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
Plný text